References
Wilson PW, Kannel WB, Silbershatz H, D’Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999; 159:1104–1109.
Goran M, Ball G, Cruz M, et al. Obesity and Risk of Type 2 Diabetes and Cardiovascular Disease in Children and Adolescents. J Clin Endocrinol Metab. 2003; 88 (4):1417.
Weisinger JR, Kempson RL, Eldridge FL, Swenson RS: The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 1974; 81:440–447.
Verani R. Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis. 1992; 20:629-34.
Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001; 59:1498–509
Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004; 89:2583–2589
Reisin E, Jack AV: Obesity and hypertension: Mechanism, cardio-renal consequences and therapeutic approaches. Med Clin North Am 2009; 93 (3):733–51.
Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000; 278:817–822.
Reisin E, Messerli FG, Ventura HO, et al. Renal hemodynamic studies in obesity hypertension. J Hypertens. 1987; 5(4):397–400.
Ruan XZ, Varghese Z, and Moorhead JF. An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol 2009; 5:713–721.
de Zeeuw D, Remuzzi G, Parving HH, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004; 110:921–927.
Reisin E, Harris K, Azar S, et al. Low calorie unrestricted protein diet attenuates renal injury in hypertensive rats. Am J Nephrol 1999; 19:433–440.
Richards RJ, Porter JR, Insierra F, et al: Effects of dehydroepiandrosterone and quinapril on nephropathy in obese Zucker rats. Kidney Int. 2001; 59:37–43.
Liao J, Richards R, Zhang R, et al. Effects of a modified low calorie diet on metabolic changes and kidney histology of young obese Zucker rat. JASN. 2005; 16:198A.
Praga M, Hernandez E, Andrés A, et al. Effects of body-weight loss and Captopril treatment on proteinuria associated with obesity. Nephron 1995; 70:35–41.
Morales E, Valero MA, Leon M et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis. 2003; 41(2):319–327.
Navarro-Diaz M, Serra A, Romero R, et al. Effects of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol. 2006; 17:213–217.
Cubeddu L, Alfieri A, Hoffmann I. Lowering the threshold for defining microalbuminuria: effects of a lifestyle–metformin intervention in obese “normoalbuminuric” non-diabetic subjects. Am J Hypertens. 2008; 21:105–110.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Soltani, Z., Reisin, E. Weight Loss: A Tool to Reduce Proteinuria. Curr Hypertens Rep 13, 96–98 (2011). https://doi.org/10.1007/s11906-010-0178-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11906-010-0178-3